CRDF
CRDF
NASDAQ · Biotechnology

Cardiff Oncology Inc

$1.60
+0.12 (+8.11%)
As of Feb 8, 2:11 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 18.16M 16.05M 19.98M
Net Income -3,051,276 -3,462,613 -3,502,482
EPS
Profit Margin -16.8% -21.6% -17.5%
Rev Growth +3.6% +0.8% +4.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 46.39M 38.47M 47.77M
Total Equity 57.89M 57.67M 59.42M
D/E Ratio 0.80 0.67 0.80
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -3,542,805 -3,307,317 -3,822,507
Free Cash Flow -2,735,833 -2,137,974 -3,204,130